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Abstract: Polyethylenimine (PEI) was combined with plas-
mid DNA and freeze dried following the addition of sucrose
as a lyoprotectant and pore-forming agent. Freeze-dried PEI
DNA condensates were dry mixed with granular polylac-
tideglycolic acid (PLGA) then compression molded and
sponged to encapsulated PEI DNA. A measurement of the
elastic modulus indicated that 91 wt% sucrose substituted
for 95 wt% sodium chloride as a porogen, resulting in PLGA
sponges with a mechanical modulus of 100 kPa. The PEI
DNA was retained (80%) within PLGA sponges prepared
with sucrose during the leaching and subsequent 2-week
release studies, whereas sodium chloride PLGA sponges
caused the premature release (100%) of PEI DNA within 2
days. In vitro gene transfer studies with PEI DNA PLGA
sponges established that adherent and infiltrating fibroblasts
expressed reporter gene for 15 days compared with the
short, 3-day expression mediated by direct gene of PEI DNA
on cells in culture. The results demonstrate an approach to
encapsulate condensed DNA in a PLGA sponge for the
purpose of retaining DNA within the matrices and creating
efficient gene transfer during tissue engineering. © 2003
Wiley Periodicals, Inc. J Biomed Mater Res 67A: 1384–1392,
2003
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INTRODUCTION
Gene delivery has the potential to treat a variety of
diseases. Recently, gene therapy found application in
tissue engineering by enhancing the rate of cell growth
and proliferation1 in a polymer scaffold.2 To enhance
uptake and expression by cells, DNA can be con-
densed with a polycation to form an electropositive
colloidal particle. The DNA condensates resist metab-
olism by endonucleases and spontaneously transfect
cells by binding to their anionic surface. Once inter-
nalized, cellular trafficking to the lysosome must be
circumvented to efficiently deliver DNA to the nucleus.3
Polyethylenimine (PEI) has been identified as a polyca-
tion for DNA condensation that mediates efficient
gene transfer.4–12 The proposed mechanism by which
PEI functions is related to its ability to buffer endo-
somes, which results in osmotic swelling and disrup-
tion of the endosomes, permitting DNA to escape into
the cytosol.4,13,14
Our goal is to design and fabricate a biocompatible
three-dimensional scaffold to replace the structural
and functional characteristics of damaged tissues. The
scaffold should display adequate tensile and mechan-
ical strength and be porous, to allow cells to infiltrate
and provide for the diffusion of nutrients, metabolites,
and growth factors.15 Polylactideglycolic acid (PLGA)
scaffolds hold promise as tissue engineering matrices
because of their ability to be engineered to meet par-
ticular requirements for mechanical properties and
degradation times. The degradation of PLGA in vivo
proceeds by simple hydrolysis, and neither PLGA nor
its degradation products are typically associated with
significant inflammation, local tissue damage, and lo-
cal or systemic toxicity in vivo.16
Several earlier investigations demonstrated the util-
ity of PLGA for polymer gene delivery in tissue engi-
neering.2 Polylactideglycolic acid sponges incorporat-
ing plasmid DNA encoding platelet-derived growth
factor (PDGF) mediated an increased vascularization
near the implant site.2 In another example, plasmid
DNA encoding pituitary thyroid hormone (PTH) was
delivered from a collagen matrix implant and shown
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to accelerate bone growth.19 Although the studies pro-
vide proof-of-principle, to apply the strategy to bone
repair requires increasing the efficiency of gene trans-
fer and retention of DNA in the matrix to allow infil-
trating fibroblasts to be transformed.
The current study attempts to advance the concept
of PLGA sponges for local gene therapy by combining
the transfection efficiency afforded by PEI with the cell
migration and ingrowth mediated by porous scaffolds
of PLGA. The combined system may result in a sus-
tained and controlled transfection of cells that migrate
into the PLGA matrix. Here we report a method to
combine PEI DNA condensates with PLGA sponges




Branched PEI (MW 25 kDa) was purchased from Sigma/
Aldrich (St. Louis, MO). Sodium chloride and sucrose were
purchased from Sigma (St. Louis, MO). Poly (d,l-lactic-co-
glycolic acid) (PLGA) 85:15 was purchased from Alkermes,
Inc. (Cincinnati, OH). Sodium 125iodide was purchased from
Dupont NEN (Boston, MA). Plasmid DNA (pCMVL) encod-
ing the Photinus pyralis luciferase was purified from Esche-
richia coli using a Qiagen column (Qiagen, Santa Clarita,
CA).
Preparation of PEI DNA condensates
The PEI DNA condensates were prepared by combining
pCMVL in Hepes buffer (5 mM, pH 7.4) with PEI (10 mM
stock) in an equal volume of Hepes buffer. The DNA (10 g)
was added dropwise to PEI (9 g) while vortexing. The
mixture was then incubated at room temperature (RT) for 30
min. Condensates were prepared at 50 g/mL and a charge
ratio of 0.5–13 (NH3
:PO4
), corresponding to 1.5–39 nmol of
PEI per g of DNA, respectively.
Particle size analysis of PEI DNA condensates
The mean particle size of PEI DNA condensates was de-
termined by quasielastic light scattering (QELS) on a
Brookhaven ZetaPlus particle sizer. The DNA condensates
(50 g/mL) were prepared as described above followed by
the addition of sucrose (160 L of 50 w/v%) prior to QELS
analysis. Condensates were rapidly frozen in dry ice/etha-
nol with in 2 min, lyophilized overnight, rehydrated with 1
mL of deionized water, and then reanalyzed by QELS.
Preparation of PLGA sponges
The PEI DNA condensates were prepared by combining
400 g of plasmid in 4 mL of Hepes buffer (5 mM, pH 7.4)
with 4 mL of PEI (360 g). Sucrose (1 w/v%) was added and
condensates were rapidly frozen in dry ice and ethanol in 5
min and then lyophilized for 72 h. Freeze-dried PEI DNA
condensates were combined with either milled sucrose or
sodium chloride (250 to 425 m) and 85:15 polylactide:
glycolide copolymer (106–250 m). Sponges were prepared
at 95 wt% (Porogen: PLGA) by combining 760 mg of sucrose
and PEI DNA condensate with 40 mg of PLGA. Alterna-
tively, sponges were prepared at 93, 91, 89 and 85 wt% by
adjusting the amount of sucrose and PLGA added. Sponges
were fabricated by compression molding 800 mg of the dry
mixture at 1500 psi for 1 min using a 13-mm die set from
Pike Technologies (Madison, WI) and a Carver model “C”
hydraulic press (Pike Technologies). The compressed pellet
(2  13 mm) was then foamed into a scaffold via a gas
foaming process16 in a custom-designed stainless steel high-
pressure vessel using dry CO2 gas at 800 psi for 24 h.
Sponges containing naked DNA also were prepared in an
identical fashion as described above.
Average elastic modulus
Sponges were leached in 25 mL phosphate-buffered saline
(PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, and
1.4 mM KH2PO4, pH 7.3) for 24 h, blotted dry, and then
compressed between two plates at a constant deformation
rate of 1 mm/min. The average elastic modulus of gas-
foamed sponges was determined on an MTS Bionix 100
mechanical testing machine from Sintech (Research Triangle
Park, NC). The stress and strain versus time was recorded
and the average elastic modulus was calculated from the
slope of the linear region of stress versus strain plot.
DNA release studies
The 125I-labeled plasmid was prepared as described in
Terebesi et al.20 at a specific activity of 534 nCi/g DNA.
The 125I-labeled PEI DNA PLGA sponges were prepared by
adding 5 nCi of 125I-DNA as a tracer before the formation of
PEI DNA condensates. Sponges were incubated in 5 mL of
PBS, and the release of 125I-DNA was monitored versus time
by gamma counting the PBS followed by replacement with
fresh PBS after each measurement.
Scanning electron microscopy
Sponges were prepared as described above and leached in
25 mL of PBS for 24 h. Following leaching, sponges were
lyophilized overnight and then bisected via freeze fracture.
Bisected sponges were sputter coated with a film of gold–
palladium alloy (AuPd) and imaged under high vacuum.
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The images were obtained using a Hitachi S-800 field emis-
sion SE microscope operating at 5 kV.
Gene transfer studies
The NIH 3T3 murine fibroblasts (ATCC, Rockville, MD)
were cultured in Dulbecco’s modified Eagle medium
(DMEM; Gibco BRL, Paris, France) supplemented with 10%
fetal bovine serum (FBS, Gibco BRL), 5000 U/mL penicillin
(Gibco BRL) and 5000 g/mL streptomycin (Gibco BRL) at
37°C in a 5% CO2 humidified atmosphere. Cells were plated
at 2  105 cells per 35-mm well and incubated for 24 h to
reach approximately 60% confluence before transfection. All
experiments were performed in triplicate. The PEI conden-
sates were prepared at charge ratios of 0.5, 1, 2, 4, 7, 9, 11,
and 13 at a DNA concentration of 50 g/mL. Before trans-
fection, the medium was replaced with DMEM supple-
mented with 2% FBS. The condensates (10 g in 200 L)
were added dropwise to the culture and incubated for 5 h, at
which time the transfecting medium was removed and re-
placed with DMEM containing 10% FBS, and cultured for an
additional 19 h before measuring luciferase expression.
Cells were washed twice with ice-cold PBS (calcium and
magnesium free) and then treated with 0.5 mL of ice-cold
lysis buffer [25 mM Tris chloride, pH 7.8, 1 mM ethylene
diamine tetraacetic acid (EDTA), 8 mM magnesium chloride,
1% Triton X-100, 1 mM dithiothreitol, threo-2,3-dihydroxy-
1,4-dithiolbutane (DTT)] for 10 min. The cell lysate mixture
was scraped, transferred to 1.5-mL microcentrifuge tubes,
and centrifuged for 7 min at 13000 g at 4°C to pellet debris.
Lysis buffer (300 L), sodium ATP (4 L of 180 mM, pH 7,
4°C), and cell lysate (100 L, 4°C) were combined in a test
tube, briefly mixed, and immediately placed in the lumi-
nometer. Luciferase relative light units (RLU) were recorded
on a Lumat LB 9501 (Berthold Systems, Germany) with 10-s
integration after automatic injection of 100 L of 0.5 mM
d-luciferin (prepared fresh in lysis buffer without DTT). The
RLU were converted into picomoles using a standard curve
generated by adding a known amount of the enzyme (0.01–
100) to 6-well plates containing approximately 60% conflu-
ent 3T3 cells. The cells were processed as described above.
Protein concentrations were measured using the bicincho-
ninic acid (BCA) assay (Pierce, Paris, France) with bovine
serum albumin as a standard. The amount of luciferase
recovered in each sample was normalized to milligrams of
protein, and the mean and standard deviation obtained from
each triplicate were reported. Dose-response curves were
generated by varying the dose of DNA while keeping the
PEI DNA charge ratio fixed at 7.
The PEI DNA PLGA sponges were sterilized with 95
v/v% ethanol for 30 min, followed by rinsing with PBS for
20 min, and two rinses with DMEM medium for 30 min. The
NIH 3T3 cells (70% confluent) were trypsinized, suspended
in 9 mL of DMEM medium, and counted in a hemocytom-
eter. A cell suspension of 104 cells in 325 L was seeded onto
the top of each prewetted sponge and then placed in 24-well
plates. The sponges were incubated at 37°C in 5% CO2 for
4 h, followed by the addition of 1 mL of DMEM. The
medium was replaced every 2 days. At the end of the
incubation, the medium was removed and the sponges were
washed with cold PBS three times, then incubated in 500 L
of lysis buffer for 1 h at 4°C while shaking. The sponge was
homogenized for 2 min at 4°C in a Polytron homogenizer.
The lysis buffer containing the homogenate was centrifuged
for 7 min at 13000 g at 4°C and 100 L of the supernatant
was assayed for luciferase and protein as described above.
RESULTS
Fabrication of PEI DNA PLGA sponges
A major difficulty of incorporating PEI-condensed
DNA into a PLGA sponge is the incompatibility be-
tween condensed DNA and the standard techniques
used to form the structures. The solvent evaporation
technique is most often used to entrap low-molecular-
weight drugs into PLGA. However, condensed DNA
is insoluble in organic solvents used to dissolve PLGA,
resulting in inhomogenous matrices when applying
classic formulation protocols. In contrast, the gas-
foaming technique involves compression of a dry mix-
ture of PLGA microspheres and a pore-forming agent
such as sodium chloride under CO2 pressure. Follow-
ing compression, the release of CO2 causes the PLGA
particles to expand into a porous spongelike structure
through the pore-forming agent. The advantage of
applying gas foaming to the encapsulation of DNA is
that the components are blended to form as a dry
mixture, thereby eliminating solvent incompatibili-
ties.21 The approach was used successfully to encap-
sulate naked plasmid DNA for the purpose of tissue
engineering.2 Following a leaching step to remove
sodium chloride, the DNA is released from the PLGA
sponge, resulting in gene transfer to cells near the
PLGA sponge implant site.2
To extend the application of the gas-foam method-
ology to encapsulate DNA, we attempted to incorpo-
rate condensed DNA into PLGA gas-foamed sponges.
Using this approach, we hoped to enhance the gene
transfer efficiency and slow the release rate of DNA so
that cells infiltrating into the PLGA matrix would be
transformed. To achieve this goal, experiments were
first designed to test the particle size stability of
freeze-dried DNA condensates. Previous studies com-
pared mannitol, sucrose, and dextran as exipients able
to stabilize the particle size of freeze-dried peptide
DNA condensates.22 Based on the results, which dem-
onstrated sucrose to be the best lyoprotectant, similar
studies were conducted with PEI DNA condensates to
determine excipients that would preserve the particle
size (Fig. 1). In the presence of Hepes buffer, either
with or without 1 w/v% sodium chloride, the particle
size of PEI DNA condensates were large (200 nm)
both before and after freeze drying. The addition of
sucrose appeared to optimally preserve the particle
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size following freeze drying, such that the addition of
10 w/v% sucrose maintained a particle size of less
than 100 nm after freeze drying (Fig. 1).
The PLGA sponges were fabricated with varying
weight ratios of sucrose in an attempt to match results
obtained with sodium chloride. The mechanical
strengths of PLGA sponges fabricated with sucrose or
sodium chloride as a porogen were compared by mea-
suring their elastic moduli. Although sodium chloride
was used in the gas-foaming encapsulation of naked
DNA, we hypothesized that sucrose would be a more
suitable porogen for PEI DNA sponges.23 The ionic
interactions that bind PEI to DNA can be disrupted at
high sodium chloride concentration, leading to the
rapid dissolution of naked DNA from a PEI DNA
sponge. The results presented below are in agreement
with this proposal.
Alternatively, the results also establish that scaf-
folds formed using 91 wt% sucrose have an elastic
modulus comparable to (100 kPa) scaffolds prepared
using 95 wt% sodium chloride (Fig. 2). Lowering the
wt% of sucrose to 89% or 85% produced a propor-
tional increase in the elastic modulus.
The porosity of each sponge was calculated by the
following equation: Porosity (%)  {1[(dry wt/vol)/
polymer density]}  100. The calculated porosities of
the sponges containing 85–95 wt% sucrose ranged
from 94% to 98%, respectively. All formulations pos-
sess a porosity of greater than 90%, which was desired
to support minimal cell ingrowth. Scanning electron
micrographs confirmed that PLGA sponges fabricated
with either sodium chloride or sucrose as the porogen
were highly porous (Fig. 3).
The release of radioiodinated DNA from PLGA
sponges prepared with sucrose or sodium chloride
were compared. The results indicated that PEI DNA
sponges prepared with 95 wt% sodium chloride re-
leased 100% of the entrapped DNA within 2 days (Fig.
4). Similar results were obtained with the release of
naked DNA from a PLGA sponge prepared with 91
wt% sucrose. In contrast, less than 20% of PEI DNA
condensates were released during 15 days from
sponges prepared with 85, 89, 91, and 95 wt% sucrose,
respectively (Fig. 4). The rapid release of PEI DNA
from sponges prepared with 95 wt% sodium chloride
was presumably the result of dissociation of PEI DNA
from the anionic PLGA matrices (Fig. 4).
Gene expression mediated by PEI DNA
To optimize gene transfer from PLGA sponges, ex-
periments were first designed to measure expression
mediated by PEI DNA added directly to adherent cells
while varying key parameters. The charge ratio of PEI
Figure 2. Mechanical integrity of gas-foamed sponges. The
mechanical modulus of leached PLGA sponges prepared
with different porogens is illustrated. Each bar represents
the average elastic modulus of five sponges.
Figure 1. Particle size of PEI DNA condensates. The QELS
particle size for PEI DNA condensates before and after
freeze drying with different lyoprotectants is illustrated.
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to DNA was systematically changed from 0.5 to 13 to
establish a charge ratio of 7, which produced nearly
maximal gene expression while minimizing excess PEI
that could be harmful to cells [Fig. 5(A)].
Fixing the charge ratio at 7, the cell seeding number
was varied, resulting in an optimal expression when
105 cells were added to wells. At a cell seeding number
fourfold higher, the gene expression decreased by
nearly 10-fold, likely because of cells reaching conflu-
ency, causing cessation of cell division [Fig. 5(B)].
The time course of gene expression was examined at
a fixed PEI to DNA charge ratio of 7 and cell seeding
number of 105 [Fig. 5(C)]. Maximal expression oc-
curred at 24 h, followed by an exponential decline,
resulting in nearly 10-fold less gene expression after
96 h [Fig. 5(C)]. A dose-response experiment estab-
lished a nearly linear relationship from 2 to 50 g of
DNA, after which increasing DNA further did not
increase the level of gene expression [Fig 5(D)].
Analysis of the in vitro gene expression mediated by
PEI DNA PLGA required a slightly modified protocol
in which cells were introduced onto a sponge placed
in the cell culture plate. After an appropriate incuba-
tion period, infiltrating and adherent cells were har-
vested from the sponge and assayed for luciferase.
Control experiments established that pipetting cells
Figure 3. Scanning electron micrographs of gas-foamed sponges. The surface pore structure of sponges prepared with 91
wt% sucrose at 50 (original magnification) (A) and 350 (original magnification) (B) are compared with similar images
prepared with 95 wt% sodium chloride at 45 (original magnification) (C) and 150 (original magnification) (D). The scale
of each micrograph is shown in the lower right corner of each panel.
Figure 4. The DNA release from PLGA sponges. The release
of PEI 125I-DNA condensates from sponges prepared with 85
wt% (Œ), 89 wt% (), 91 wt% (), and 95 wt% (‹) sucrose are
compared with sponges prepared with 95 wt% sodium chlo-
ride (■). In addition, the release of naked 125I-DNA from a
sponge prepared with 91 wt% (F) sucrose was tested.
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onto the sponge promoted adherence and infiltration
compared with overlaying a PLGA sponge onto al-
ready adherent cells (data not shown). Further control
studies also confirmed that only cells that adhered to
or infiltrated into the PLGA sponge expressed reporter
gene, whereas cells that were adherent to the culture
plate were not transformed (data not shown).
By comparison, the gene transfer efficiency medi-
ated by PEI DNA PLGA sponges containing 50 g of
DNA was approximately 100-fold lower relative to
direct gene transfer of 10 g of PEI DNA to adherent
cells (Fig. 6). The difference between the two is that in
the latter case nearly all of the DNA is immediately
available to cells, whereas in the former, the majority
of the DNA remains entrapped and inaccessible to
cells external to the sponge over this time.
Comparison of the expression mediated by PEI
DNA PLGA sponges prepared with 85–95% sucrose as
a porogen established maximal expression at days
3–6, which declined threefold or fourfold by day 15
(Fig. 6). The gene transfer efficiency was indistinguish-
able for sponges prepared with 85%, 89%, or 91%
sucrose but increased severalfold for sponges pre-
pared with 95% sucrose. This likely resulted from a
decrease in the cell growth and associated protein
recovered from the culture, because of the mechanical
instability of 95 wt% PLGA sponges. Interestingly, PEI
DNA sponges prepared with sodium chloride as the
porogen (85–95 wt%) were completely inactive in gene
transfer as were PLGA sponges containing naked
DNA (not shown). These data support the hypothesis
that sodium chloride caused rapid loss of PEI DNA
during the leaching step. The results also established
that the gene transfer was much more sustained when
Figure 5. In vitro gene expression of PEI DNA in NIH 3T3 cells. Luciferase reporter gene expression for PEI DNA
condensates as a function of PEI DNA charge ratio (A), cell seeding number (B), gene expression time course (C), and DNA
dose (D) is illustrated. Each bar represents the mean and standard deviation of the triplicate transfections.
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transforming cells in PLGA sponges compared with
direct gene transformation of adherent cells.
The level of gene expression was influenced by the
number of cells seeded onto PLGA sponges but was
not significantly different between the optimal range
of 105–106 cells (Fig. 7). As observed when transform-
ing adherent cells, the charge ratio strongly influenced
the expression mediated by PEI DNA entrapped in
PLGA sponges, with a maximal gene expression at a
charge ratio of 5 or higher (Fig. 8).
The dosing range was varied from 2 to 1000 g in
PEI DNA sponges prepared with 91 wt% sucrose. The
results indicated a flat dose response between 2 and 20
g, followed by a proportional dose response up to
250 g, with no additional increase up to 1000 g of
DNA (Fig. 9).
DISCUSSION
In a previous study, naked plasmid DNA was in-
corporated into a PLGA sponge and used to demon-
strate its utility in tissue engineering in vivo.2 The
DNA encoding either -galactosidase or PDGF was
combined with sodium chloride, freeze dried, and
then used to make PLGA sponges in a procedure
analogous to that presented here. The DNA-loaded
PLGA sponges were leached to remove sodium chlo-
ride, then implanted in a subcutaneous pouch in rats.
Two notable consequences of this experiment were
that a large percentage of the DNA was released from
the sponge prematurely during the leaching step, and
cells external to the sponge implant were trans-
formed.2
In the current study, we attempted to improve on
the previous design by entrapping PEI DNA in the
PLGA sponge, allowing transfection of infiltrating
cells, with higher gene transfer efficiency relative to
Figure 6. Time course of gene expression from PEI DNA
PLGA sponge. The luciferase gene expression during days
3–15 for PLGA sponges prepared using 85, 89, 91, and 95
wt% sucrose are illustrated relative to a control sponges
prepared with 91% sucrose and naked DNA. Each sponge
contained 50 g of DNA seeded with 104 cells.
Figure 7. Influence of cell seeding number on PEI DNA
gene transfer from PLGA sponges. The cell seeding number
was varied from 104 to 107 for gene transfer from PLGA
sponges prepared with 91 wt% sucrose and 50 g of PEI
DNA while measuring luciferase expression at day 3.
Figure 8. Influence of PEI DNA charge ratio on gene trans-
fer from PLGA sponges. The PEI DNA charge ratios were
varied from 0.5 to 11 in PLGA sponges prepared with 91
wt% sucrose and 50 g of DNA.
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that achievable with naked DNA. To accomplish these
goals, we attempted to incorporate PEI DNA conden-
sates, which are known to be efficient mediators of
gene transfer in vitro and in vivo. To formulate dry PEI
DNA condensates with an appropriate porogen and
granular PLGA, we first established that sucrose was
compatible with the gas-foaming process and simul-
taneously would preserve the particle size of DNA
condensates. Using the elastic modulus as a measure
of sponge stability, 91 wt% sucrose was found to
substitute for 95 wt% sodium chloride, whereas lower
sucrose concentrations were able to produce sponges
that were significantly more stable.
In addition to being compatible with the gas-foam-
ing technique, sucrose facilitated the retention of PEI
DNA within the sponge during the leaching step. As
demonstrated in Figure 4, very little of the DNA is
released over time, suggesting it is bound through
electrostatic interactions with PLGA. Sucrose was thus
found to be a substitute porogen that resulted in re-
tention of condensed DNA in the sponge while main-
taining the porocity and mechanical stability of the
sponge.
Although the gene transfer properties of PEI DNA
condensates were studied previously,24,25 we sought
to compare the efficiency of gene transfer using opti-
mal conditions of charge ratio, dose, cell seeding num-
ber, and time of expression with and without a PLGA
sponge in a fibroblast cell line. The results indicate that
although direct gene transfer of PEI DNA condensate
onto adherent cells produces a higher level of gene
expression, the duration is much shorter compared
with gene transfer from a PLGA sponge. Likewise,
only cells that bind to and infiltrate into the pores of
the PLGA sponge are transformed. This is consistent
with the location of the PEI DNA, which remains
inaccessible to cells outside the matrices.
It is interesting to speculate on the mechanism of
gene transfer within the PLGA matrices. Presumably,
infiltrating cells encounter immobilized PEI DNA and
capture it from the surface of the PLGA sponge. Con-
sequently, at low PEI DNA loading levels, the gene
transfer is relatively inefficient because of the infre-
quent encounters of PEI DNA and infiltrating cells,
whereas at optimal loading, PEI DNA is more densely
dispersed throughout the matrices, resulting in either
the transformation of more cells or multiple transfec-
tion events for cells penetrating further into the ma-
trices. At very high loading levels, PEI DNA may form
aggregates within the matrices that sequester the
DNA, making it less accessible for gene transfer.
It is also clear that the PEI DNA charge ratio
strongly influences the gene transfer efficiency. At a
charge ratio of 2:1 or higher, DNA is fully condensed
and can no longer bind additional PEI. However, ex-
cess PEI is likely retained in the PLGA sponge through
electrostatic interaction and can participate in gene
transfer via a mechanism that is proposed to involve
the disruption of endosomes, allowing the escape of
DNA.
Although PEI DNA is known to exert toxicity to
cells when delivered in high concentrations,23,26 we
found no evidence of cellular toxicity from PEI DNA
PLGA sponges when conducting dose-response ex-
periments. Likewise, based on the measurement of
total cellular protein, PEI was not found to be toxic to
cells at charge ratios (N:P) as high as 11:1. This may be
a result of sequestration of the excess PEI on the
surface of PLGA surface until the time of cellular
encounter. The PEI would be expected to ionically
bind to PLGA, making it less able to crosslink proteins
on the cell surface, leading to membrane disruption.
Future studies will examine the ability of PEI DNA
PLGA sponges to mediate gene expression in vivo,
with the aim of using the scaffold to direct cellular
infiltration and formation of tissue.
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